Apollo Hospital Enterprises
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Apollo Hospitals is positioned for sustained growth, driven by a robust expansion strategy targeting 14,100 beds by FY31 and a focus on enhancing its digital health ecosystem. Management's optimistic outlook is supported by strong inpatient volume growth and operational efficiencies, although the gestation period for new facilities may temporarily impact margins. The company's strategic initiatives, including the upcoming demerger of its pharmacy business, are expected to unlock shareholder value and improve capital allocation. Vista's financial outlook reflects stable revenue growth and margins, with a fair valuation aligned with intrinsic value. The healthcare sector's favorable dynamics, including rising demand for organized care and increasing insurance coverage, bolster Apollo's competitive position. However, potential headwinds such as regulatory risks and margin pressures from new hospital ramp-ups warrant close monitoring. Over the next 12-24 months, key opportunities include the successful execution of capacity expansion and digital integration, while watchpoints include the pace of occupancy in new units and competitive intensity in the pharmacy sector
Why We Like This Stock
- Strong inpatient volume growth and operational efficiencies are driving revenue stability
- The strategic demerger of the pharmacy business is expected to unlock significant shareholder value
- Rising demand for organized healthcare services and increasing insurance coverage enhance market opportunities
Things To Watch Out For
- The gestation period for new hospitals may temporarily impact margins and profitability
- Regulatory risks related to potential price caps on hospital services could affect revenue
- Competitive pressures in the pharmacy sector may challenge margin stability
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 19,059 | 21,794 | 25,228 | 27,136 | 31,276 |
| Profit Before Tax (Cr.) | 1,344 | 1,968 | 2,680 | 3,103 | 3,650 |
| PBT Margin | 7.1% | 9.0% | 10.6% | 11.4% | 11.7% |
| Net Profit (Cr.) | 922 | 1,465 | 2,046 | 2,361 | 2,694 |
| Earnings Per Share | 61.6 | 97.8 | 138.0 | 159.3 | 187.4 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| BofA | ▲ Buy | 10,600 | 24-Sep-2026 |
| JMFinancials | ▲ Buy | 10,446 | 17-Aug-2026 |
| Elara Capital | ► Accumulate | 9,470 | 14-Aug-2026 |
| ICICI Securities | ► Hold | 8,500 | 14-Aug-2026 |
| JPMorgan | ▲ Buy | 10,800 | 14-Aug-2026 |
| Moneycontrol | ► Equalweight | nan | 14-Aug-2026 |
| Motilal Oswal | ▲ Buy | 10,160 | 14-Aug-2026 |
| Nuvama | ▲ Buy | 9,900 | 14-Aug-2026 |
| Prabhudas Liladhar | ▲ Buy | 10,000 | 14-Aug-2026 |
| Citigroup | ▲ Buy | 10,770 | 13-Aug-2026 |
| Kotak Securities | ▲ Buy | 9,520 | 13-Aug-2026 |
| Macguire | ▼ Underperform | 6,230 | 13-Aug-2026 |
| Morgan Stanley | ▲ Overweight | 10,158 | 13-Aug-2026 |
| Choice Equity | ▲ Buy | 9,600 | 22-May-2026 |
| Goldman Sachs | ▲ Buy | 8,850 | 22-May-2026 |
| HDFC Securities | ▲ Buy | 9,680 | 22-May-2026 |
| HSBC | ▲ Buy | 9,000 | 21-Apr-2026 |
Company Overview
Show Company Profile
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.